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Identification and characterization of urokinase receptors in natural killer 
cells and T-cell-derived lymphokine activated killer cells 
1. INTRQDWCTION 
The plasminqcn activator tirokinasc (uPA) is 
secreted as a sin& chain procnzymc (pro-UPA). which 
binds to uPA remptm (uPARI of a v&cry of c&s. 
uPARs ark 313 re~iciu~ glycsrprutcins [I] litirgdv 
anchored to the plasma membrane by a C-terminal gly- 
and 
invasion of tumor cells 
Plasminogen inhibitors. 
e.g, plasminogen &v&or inhibitor (PAI-I). 
which a stable with uPA. It has 
shown uPA:PAI-I are removed 
from the surface by 
diisopropylfluc?rophosphat~ [“‘I]DFP-uPA. 
‘“I-lab&i and DFP-treated uPA; FACS. Ruoresccnce-aetivatcd cell 
scanning: LAK cells. Iymphokine activated kitler-cells: LGL. targc 
granular lymphocytcx PAM. plasminogcn activator inhibiror r?p-i, 
PPD. purified prowin Jerivatire; uPA. urokinasc iypc phsmmocn 
activator; uPAR. rcccptor for uPA. 
Currespon&we oddre.w A. Nykjax, lnsiituk or Medicai Biwhcmis- 
try, Ole Worms All& 170. University or’ Aarhus. DK-MtKI Aarhus c‘.. 
Denmark. Fax: (15) 86131160. 
followed by dgmdation in the monacytoid ccl1 line. 
UWf m. and the chdcmcinoma cd iinc, Jr. !. 
PIEGOUS work has shown that monocytes (9~ and 
polymorphonuchxw kucacytm [W] arc uPAR-bearing. 
This has also been report& for 6-c&. whereas T-c& 
itrc thought IU bc uPAR-negative ilO& WC: have u_scd 
fluomccnce-activated cell scanning (FAGS) to annlysc 
the occurrcncc of uPAR in human lymphocytes. WC 
report hitherto unrecognized uPAR in large granular 
Iymphocytcs (LGL). which constitute active NK cells. 
and intcrlcukin-2 (IL-Sactivatcd T-cells (LAK cells). 
In contrast to monocytes. LAK cells did not dcgrodc 
u?AR-bound uPA:PAl-I complexes. Rcccnt work has 
shown that LAK c&s. which possc3s anti-rumor activ- 
ity. Mg he-Z thr microcirculation and infiitratc pulmo- 
rl?ry mctastxsis I! 11 Ox 5&;,g.. r-+X5? 1% iltly% 
ti0n oi6Xll surface-organized plasminopn irCii\aIi0r: in 
t lhzir cxtnvasation. 
2. MATERlAD AND METHODS 
2.1. R%-qtvrr 
Human rrxombinant IL-I was from Amham. UK. f’horphabd>- 
linositolphospholip;l~Caasfmm Bochrin~-‘dannhcim.Gr~an?. 
Humx~ two-chain uPA was fmm Scrono. Switzerland. Pro-uPA 
(sin&z chain UPA) ws purified from strum-free conditioned medium 
of human HT-IORO dk asderribed previously [8]_ uPA was catal+ 
ally inactix&xl v;ilh diisopropylfluoro-phosphate t DFPl a5 dc- 
scribed [9]_ uPA and DFP-uPA wzre iodinatcd to a spxific activity of 
abut 9x10” Eq’mol using chforamin-T as Ihc oxidizing EQX!TII 191. 
?3 C!:.i;:r’ :..;,xl- ‘53 .- pi 83 n&l up.4 in 0. i M NaHm,. pH 9 8. XGV. 
ad&d to 250~1 I mM biotin-,V-hydrony-succinamidc1Sigma1 in dimc- 
thylfcrmsmidc followed by incubarion for I h at ST and di;ll>ri% 
apInsr ~~osphate_bu%ed saline. pil 7.2. uith _Wck &CCTO~. &O~U+ 
up4 w:+ ic+,tinSuishable from uPA and DFP-uPA a* inhibitor ~11. 
binding of (‘“IIDFP-uPP (cf. Fig 31. 
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Humun PAI-I wus puriflcd by immunodllnicy hromatoaruphy 
from scrum-kcc conditioned medium d HT-IOX0 ceils cultured with 
dcxumcth;rsonc [R], Lnhcicd uPA:PAI-1 complex WM prcpi~rcd by 
incllhatinfl I pg/lai ['z"l]~~PA with IO pplt111 SDS-~I~~IV~I~~~ PAI-I [I21 
in 0.1 M Tris. 0.1% Triton X-100. pH 8.1, for I h 411 20°C kdhwd 
5~ ~ISNI~C through rrnliBhl4 lgC3 irnd anti-uPA-IHI columns jRJ, 
The murinc monoclonai untihody (clone 6) wnn ngninsl the N-tcrmiunl 
pnrt ol’uPA contnining the rcecplor binding domtiin [I% 
Humlm pcrirhcrlil hload mononuclctir cells wcrc prcpnnd from 
citrate-Fhorpharc-dcxlr~~c, mhillml bulQ cou1s by llolnllon on 
lanFnqtlEgFicoll,:Monocyt~~ wcrc IrointcJ IR the populnrion ndhcrlna 
to plnrtic dishes ulW incaWon for I.5 h nt 37OC [PI. Thecrythrocylc- 
~nacttc.f~rmin~ t&lion p 95% CO3t) wn~ irohrlcd from the non- 
nihcrcnt cells urinv shq ml blood C&I tr~nl~xl whh 1% s-(2- 
uminoclhyl’-iaothiottmnirtm followed by ccnlrifugation on Ficoti. nnd 
dcsipnnrcd tne T.ccil Itnclian. The non-roalting ceils, conlaintng 6% 
~0% SD2Ot calls, wnr dcaignslctl Ihc El-cell cnrichcd knction. Poly- 
morphonuclcnr lcucocyba wcrc prcfwxi from hu@ conla udnp 
~crcoil grndicnl cmri(\lpnlion s dmcrihcd [Ml. LAK cclia WCIC 
prcpnrcd hy culturing (1-2 x IO” cc\lnlmi, 5% CO3 in ntmorphcric air) 
the T-ccl1 kwion in r.RPMI (Qibco, UK) conltiinlng IO4 1111 IL-2. 
Fresh IL-?; wnr nddcd cvcry third dny nnd the ccll~ (3PS’IF CD]+, no 
SDI6+) wcrc harvested hy ~tboul IO ~IIYJ. 
The cciia wcte incuhntcd with hiotin-uPh, wnahcd rind rc?.u!ipcndcd 
in phoaphutc hull’cmi mlinc, pH 7.2, contninin% Wcpcnvidinc.~phy- 
cocrythrininc rrad FlTSH-conjugnled ceil mnrkcr unlihodics (Rcclrin 
Dickinson). Albr 30 mln in the dark, the cells wc!cn: wnnhcd, re- 
auspndcd und nnniyacd in R FASWn flowvcytamclcr (Rcclon Dick- 
insonl. 
Sclis wcpc wnshcd nnd incubl\tcd with inbclcd und uninbcicd lipmxlx 
in I24 mM NaSI. 4.7 mM KCI, 2-S mM CAMS&. I 2 mM MgSD,. 2.5 
mM NaH,PO,, 25 mM HEPES. I % hovinc strum albumin, S jrplml 
Trnsyloi. pH 7.4. The incubations wcrc tcrminutcul by the ndditior~ of 
25Opi suspension to micmfigc tubes containing 200,ui siiiconc oil. D 
I .OZS. foliowcd by ccntrifugnlion p]. The tube wns cut nnd liic pcllct 
nssaycd for radioactiviry. Triton X-i I4 dctcrgcnt phase cntmcts used 
for blotdng of (“511DFP-uPA (cf. Icgcnd to Fig. 3, inset) wcrc prcpnrcd 
as dcscribccl by Rfhlrndr tt al. (IS]. lo hricf. 2 x IO” cciis wcfe lysnt 
in 4 ml 0.1 M Tris. I% Triton X-i 14, IO mM EDTA. I mM PMSF. 
IO jr@rnl Trasyiol, pH 3.1, :\I 0°C. Tlic iysutc WIS cinrificd by ccn. 
lritip~tion, incubntcci for 10 r,iin ilt 37’C to indurx the p&c scpara- 
tion. rcsusmded nt WC, rc-incubntcd nt 37°C and fin& saspcndcd 
in ? ml 0.1 M Tris with 0.59 CHAPS IO avoid tcml#‘riltrlrr-irldllrvrl 
pnaso scpakkn. 
3. RESULTS 
The B-cell cnrichcd fraction bound specifically 3.7 + 
0.3% (S.D.. tt = 3) of 5 pM [““I]DFP-uPA ( IOh cellshnl, 
16 h at 4T). as compared with I I ,4 k O.S% for mo- 
nocytes and 3.2 5~ 0.3% for polymorphonuclear leu- 
coeytes. Fig. IA shows by FACS analysis that about 
half of the NK (CDl6+) cells present in the B-ccl1 cn- 
riched fraction were receptor-bearing. None of the B. 
cells (CD20+) were receptor-positive (not shown). 
Analogous experiments also revealed receptor hetero- 
Seneity among monocytes as previously shown by auto- 
radiography 191. Fig. 18 shows that the rcccptor-posi- 






Fig. I, ninding al hiorin-uPA to NK ceils. Wood mtrannuclcar c&la 
wcrc inculultcd for Id h nt PC with cithcr 200 pM hi&&A done 
or ~IIIR XM nM uninhclcd uPA. foiiawcd hy rhc uddhion crf strcpta- 
vldin-phycocrylhrln nnd FlTC-conjun~~atcd untlhodlcr ayinrr the 
SD16 untigcn, The ptc WI\% ~1 lo aclcct COW (NKI cella W The 
~~~IsMI Jhow ceil-hound hlatln-ufA cxprcsJFa (II the lluorexence 
signnl (FL) rrnd!hc ardlnnrc show thc&zll counrr(W: did line, .%lb 
pM hiolin-uPA nlnnc; dortcd line. hiolin-uPA ~iur -%“ltI nhl unlaclhfki 
uPA, (R) The abxlssn show granulation cxprcsti 88 side scrrttct 
~SSCI:thc~pror-~crairivcSDI(I+ populntian isshmvnti3hIhcxGt.l 
lint rtntl the muplor-ncgnGve pop~tlrr~ion bg the hrekcn tine. 
receptor-ncgntive ceurlls. Similar analysis using forward 
scatter (:I measure of cell size) shawcd a larger average 
size of the receptor-pasitivc cells. Thus. the NK cells 
able to bind uPA may be classified marphologically as 
large granular lymphocytes (LGL), and they appear to 
account for the uPA binding of the B-031 Caction. 
The T-cell fndion exhibited <lb binding of 
I”sI]DFP-uPA: the cullured cell lint Jurkat was I-C- 
ceptor-ncgativc (not shown), FACT anal-y& (Fig. 2A) 
rcvcalcd a small subsei of receptor-positive blood- 
dcrivcd T-cells. Fig. ?D snows that cui~uring or” thu T- 
cell fraction with IL-2 resulted in a population of largely 
(70-80%) IWCptCW-IXiWltlg CX+ *Y9, T!lC s::? WSdP 
(not shown) wss obtainLu! v:.+cr ;r\sp.- :!~.?xrent blood 
mononuclear cells were cultured with IL-2, Culturing 
peripheral bload mononuclear cells for 5 days with 
purified protein derivaGve (PPD), which generated 
>95% CD3+ T-cells. increased binding to 4.7 + 0.1% 
(i0’ cells/ml) as compati to 5.9 + 0.3% with IL-2. The 
PPD effect was maximal by 9 to 10 days after a lag time 
cf at least 3 days. Long-term incubation with PPD is 
known to induce IL-2 secretion by T-helper cells, and 
the effect is therefore most likely caused by this cy- 
tokine. 
IL-Zactivated T-c&, like those iltustratcd in Fig. 
28, caused lysis of Daudi cells and could therefore be 
classified as lymphokine-actilrated killer (L-AK) cells. 
This Iysis seemed indcpcndent of uPAR occupanq 
since incubation with 10-1000 pM cataly:ically active 
uPA for up to 24 h had no effect (data not shown). 
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hitial binding e-wiment~ with LAK cells showed 
no cfkt of ~4% wash (pH 3.QI. ,i 
endogcnous occupancy sr UPAR. cu 
cell extracts did not contain detcctabk Icwts of UPA. as 
determined by ELlSA and qmography. su tin8 lack 
of uPA synthesis. Fig. 3 shows an apparent & of about 
60 pM at 4% and the wne binding curve was obtained 
when using labeled uPA:PAl-I comples. Analogous cx+ 
perirnents (not demonstrated) at 37T showed an ap- 
parent & of about 150 pM. i&and blotting revealed an 
approximately 50 RDa uPAR in LA); cells as in mo- 
nqtes (Fig. 3. inset) in agrccmcnt with uPAR purifier! 
from UK47 cells [IS]_ Binding to the nxeptor protein 
ws blocked by er;ccs~ snlabclcd UPA and inhibited by 
the monoclonal antibody dirrctti against the reccplor- 
binding dox:nirr o? uP.4. bur noa by anrib& directed 
against PAI- 1 _ 
Prmeatmcmt with 1 U/ml phosphatidylinositol-phos- 
phoiipase C (I h. 37T) reduced binding more than 90% 
(rwt shown). suggesting almost complete glycolipid 
anchoring of uPAR. whereas binding was reduced only 
S-60% in monocytes as reported prwious~y for U937 
cells p]. The following results were as reported for mo- 
nocytes [9]: binding of DFP-uPA. pro-UPA. catalyti- 
cally active uPA and uPA:PAI-1 complexes were of the 
same magnitude: tissue type plasminogen activator. 
alone or in complex with PAI-I. did not inhibit binding 
of [“51jDFP-uPA. 
Fig. 4A shows that uPAR-bound-[“5i]DFP-uPA as 
well as [‘:‘I]uPA:PAi-I dissociated almost entirely as 
the $*a~! tracers at 37°C in L_4K cells. $2 c92trac;, zr; 
shown in Fig. 4B, appreciable rweptor-mediated degrz- 
dation was observed in blood-derived monocytes: 20% 
March WC! 
lw c. m-M. 
PAI-I. 
ihe l’-“I]DFP-uPA and 60% of the [‘-“lJuPA:PAI-i. that 
had dissociated to the m&urn by J h, were low mok- 
ulat we&i,: &gtadarion products. 
J. DlSCUSSION 
This communication demonstrates uPAR in subsets 
of NK cells (CDM) and T-cells (CD3+). Both ccl1 
classes secrete HuTSP-I. an effective activator of pro- 
UPA [3.4]. We find that UPA binding to the B-cell en- 
riched blood cell fraction is largely accounted for by the 
subset of NK cells characterized as LGL. whcrcas B- 
cells (CDZO+) are u-PAR negative. LGL account for thz 
NK activity in blood [t6]. secrete pro-ul-‘A [lij and arc 
abtc to migrate in contrast to B-cells f IS]. Future studies 
should show whether the secretion & HuTSP-I in NK 
c& ii z1-;,, accounted for by LGL. 
@inding of UPA to bloodderived T-cells has previ- 
ously csczped notice [lo]. presumably because oni! a 
smaT1 fraction is receptor-bearing. The markedly in- 
c@ expression following cultuw with IL-2 ma->- qua- 
lify uPAR as an activation antigen. Interesting&‘. 1%~ 
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Fig. 4. Dissrw‘iation and dugrudnti\r\\ of prcbouttd DFP-\\PA t\\\d 
uPA:PAI-1 in LAK cells (A) i\ttd nwnocy~cs [B). The CCIIS IWW in. 
culx\t~~I for 16 h at 4°C with IO pM j”“l]DFP-uPh (filled symbols) 
or [\:~l]uPh:Phl-l (open symbols), wtshcd \\nd t~\nsl’crtal IO 37°C 
(time zero. cell-ussociatcd r;\diot\ctivity set t\t 10081. R[\diw\cti\*ity 
xmnitting uPAR-bound (W 0); ntdionctivity a\ppct\rittg in the 
\ncdi\\nt i\s trichlowtcctic i\cid-solt\hlc (6, ;z) or -prccipitc\btc (A. .I) 
\ni\tcriul. Dcgrudation oC thl: tr;trCFs W\S nsgligiblc in both LAK-wII 
uttd manllcytccl~nditioncd mcdiuru. & di%soGiatcd ncid-pwcipirahlc 
tnt\tcrit\l \vns innct DFP-\\PA or \d’A:PAI-I us judged hy rebinding 
to tirsh culls ;\nd SDS-PAGE. The twt\Its ;\t+c tttci\ttw of tripliutws + 
1 S.D. 
Mo3 activation antigen cxprcsscd on the plasma mcm- 
brane of human mononuclear phagocytcs has rcccntly 
been identified as uPAR [lY]. 
uPAR of IL-&activated T-cells did not mediate dcg- 
radation of uPA:PAI-I, even though LAK cells intcr- 
nalizc and degrade receptor-bound TNF-er [20]. This is 
in contrast o the results on monocytcs with uPA:PAI-1 
and previous results [21] with uPA:plasminog:n acti- 
vator inhibitor type-2 complexes. Since treatment with 
phosphatidylinositol-phospholipase C removed nearly 
all UPA binding from LAK cells, but only 50-60~ from 
monocytes. we thought that glycolipid-anchored uPAR 
might bc unable to undergo endocytosis. Howe .zr. this 
explanation is unlikely eincc the same fraction of mo- 
nocytc-bound uPA was dcgrrtdcd whcthcr or not the 
cells wcrc prctrcatcd with phospholipasc C (unpub- 
lishcd observation). In uny cvcnt, surface-cxprcsscd 
uPAR in LAK cells appears non-susccptiblc to the 
down-rcgutntion induced by uPA:inhibitor complcxcs 
in monocytcs, 
WC were unable to dctcct synthesis of pro*uPA in 
LAK cclls,~ cvcn though they can cxtravaratc and 
migrate [l I]. and they may thcrcforc rely on binding of 
exogenous pro_uPA, The blood concentration of pro- 
uPA/uPA is about 15-25 pM [22] implying a receptor 
occupancy of about 20% (npp. & ca. 150 pM at 37OC), 
and higher occupancies of pro-uPA arc cxptcd in the 
ncighbourhood of macrophagcs. Future studies should 
show whether the population of activntcd T-c& rich in 
uPAR is also the population sccrcting HuTSP-I. If so, 
this may provide an cfficicnt autocrinc mcckanism for 
activation of cdl-aasociatcd pro-UPA and activation of 
plnsminogcn as one of the cvcnts facilitating cxtravasa- 
tion and nligralion. 
,.lc~k,t~nr~/\~~~~~~~rrcnts: S\\pportcd by gtx\nts rmtn the Danish Birr- 
\ttcntbr\\\\c Rcsct\luh Ccntcr. Nordic Insulin Foundation. the Dwish 
Mdicd Rcscnrch Cottncil (A.N. IUMI J.Q.), the Dunish Cnncer Soday 
I&N.. P.A.A. unrl J.G.) ttnd thu Di\niah Blaod Dontm Rwweh 
Fo\tt\dt\dott (C.M.P. und R.M.). 
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